Literature DB >> 22418032

Bystander-mediated stimulation of proteolipid protein-specific regulatory T (Treg) cells confers protection against experimental autoimmune encephalomyelitis (EAE) via TGF-β.

Sangmu Jun1, Javier Ochoa-Repáraz, Dagmara Zlotkowska, Teri Hoyt, David W Pascual.   

Abstract

To assess the potency of regulatory T (Treg) cells induced against an irrelevant Ag, mice were orally vaccinated with Salmonella expressing Escherichia coli colonization factor antigen I fimbriae. Isolated CD25⁺ and CD25CD4⁺ T cells were adoptively transferred to naive mice, and Treg cells effectively protected against experimental autoimmune encephalomyelitis (EAE), unlike Treg cells from Salmonella vector-immunized mice. This protection was abrogated upon in vivo neutralization of TGF-β, resulting in elevated IL-17 and loss of IL-4 and IL-10 production. Thus, Treg cells induced to irrelevant Ags offer a novel approach to treat autoimmune diseases independent of auto-Ag.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22418032      PMCID: PMC3328618          DOI: 10.1016/j.jneuroim.2012.02.003

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  74 in total

1.  Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis.

Authors:  Harald H Hofstetter; Saleh M Ibrahim; Dirk Koczan; Niels Kruse; Andreas Weishaupt; Klaus V Toyka; Ralf Gold
Journal:  Cell Immunol       Date:  2005-12-28       Impact factor: 4.868

2.  Regulatory T cell vaccination without autoantigen protects against experimental autoimmune encephalomyelitis.

Authors:  Javier Ochoa-Repáraz; Carol Riccardi; Agnieszka Rynda; Sangmu Jun; Gayle Callis; David W Pascual
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

Review 3.  The origin and application of experimental autoimmune encephalomyelitis.

Authors:  Alan G Baxter
Journal:  Nat Rev Immunol       Date:  2007-11       Impact factor: 53.106

4.  Drug trials. Violent reaction to monoclonal antibody therapy remains a mystery.

Authors:  Eliot Marshall
Journal:  Science       Date:  2006-03-24       Impact factor: 47.728

5.  IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis.

Authors:  Yutaka Komiyama; Susumu Nakae; Taizo Matsuki; Aya Nambu; Harumichi Ishigame; Shigeru Kakuta; Katsuko Sudo; Yoichiro Iwakura
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

6.  Involvement of cellular death in TRAIL/DR5-dependent suppression induced by CD4(+)CD25(+) regulatory T cells.

Authors:  X Ren; F Ye; Z Jiang; Y Chu; S Xiong; Y Wang
Journal:  Cell Death Differ       Date:  2007-08-31       Impact factor: 15.828

7.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

Authors:  Marc Veldhoen; Richard J Hocking; Christopher J Atkins; Richard M Locksley; Brigitta Stockinger
Journal:  Immunity       Date:  2006-02       Impact factor: 31.745

8.  IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells.

Authors:  Akihiro Kimura; Tetsuji Naka; Tadamitsu Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-10       Impact factor: 11.205

9.  Low-dose tolerance is mediated by the microfold cell ligand, reovirus protein sigma1.

Authors:  Agnieszka Rynda; Massimo Maddaloni; Dagmara Mierzejewska; Javier Ochoa-Repáraz; Tomasz Maslanka; Kathryn Crist; Carol Riccardi; Beata Barszczewska; Kohtaro Fujihashi; Jerry R McGhee; David W Pascual
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

10.  A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis.

Authors:  Caroline Sutton; Corinna Brereton; Brian Keogh; Kingston H G Mills; Ed C Lavelle
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

View more
  12 in total

1.  The gut microbiome in multiple sclerosis.

Authors:  Daniel W Mielcarz; Lloyd H Kasper
Journal:  Curr Treat Options Neurol       Date:  2015-04       Impact factor: 3.598

2.  Expression of a second ecto-5'-nucleotidase variant besides the usual protein in symptomatic phase of experimental autoimmune encephalomyelitis.

Authors:  Irena Lavrnja; Danijela Laketa; Danijela Savic; Iva Bozic; Ivana Bjelobaba; Sanja Pekovic; Nadezda Nedeljkovic
Journal:  J Mol Neurosci       Date:  2014-10-19       Impact factor: 3.444

Review 3.  Gut commensalism, cytokines, and central nervous system demyelination.

Authors:  Kiel Telesford; Javier Ochoa-Repáraz; Lloyd H Kasper
Journal:  J Interferon Cytokine Res       Date:  2014-08       Impact factor: 2.607

4.  Thymic atrophy creates holes in Treg-mediated immuno-regulation via impairment of an antigen-specific clone.

Authors:  Rachel Thomas; Jiyoung Oh; Weikan Wang; Dong-Ming Su
Journal:  Immunology       Date:  2021-04-15       Impact factor: 7.215

5.  Immunomodulatory activity of polysaccharides isolated from Clerodendrum splendens: beneficial effects in experimental autoimmune encephalomyelitis.

Authors:  Koffi Kouakou; Igor A Schepetkin; SangMu Jun; Liliya N Kirpotina; Ahoua Yapi; Daria S Khramova; David W Pascual; Yury S Ovodov; Mark A Jutila; Mark T Quinn
Journal:  BMC Complement Altern Med       Date:  2013-06-28       Impact factor: 3.659

Review 6.  Gut Microbiota in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Current Applications and Future Perspectives.

Authors:  Fengna Chu; Mingchao Shi; Yue Lang; Donghui Shen; Tao Jin; Jie Zhu; Li Cui
Journal:  Mediators Inflamm       Date:  2018-04-02       Impact factor: 4.711

Review 7.  Nutritional and ecological perspectives of the interrelationships between diet and the gut microbiome in multiple sclerosis: Insights from marmosets.

Authors:  Maria Elisa Perez-Muñoz; Scott Sugden; Hermie J M Harmsen; Bert A 't Hart; Jon D Laman; Jens Walter
Journal:  iScience       Date:  2021-06-10

Review 8.  Regulatory T-cell vaccination independent of auto-antigen.

Authors:  David W Pascual; Xinghong Yang; Kathryn Holderness; SangMu Jun; Massimo Maddaloni; Irina Kochetkova
Journal:  Exp Mol Med       Date:  2014-03-14       Impact factor: 8.718

Review 9.  Gut microbiome and the risk factors in central nervous system autoimmunity.

Authors:  Javier Ochoa-Repáraz; Lloyd H Kasper
Journal:  FEBS Lett       Date:  2014-10-05       Impact factor: 4.124

10.  Neuroimmunological Implications of Subclinical Lipopolysaccharide from Salmonella Enteritidis.

Authors:  Anita Mikołajczyk; Dagmara Złotkowska
Journal:  Int J Mol Sci       Date:  2018-10-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.